המודל הפתוח של מדור יחיד למתן תרופה בעירוי בולוס תוך-ורידי: הערכת ניקוי

Clearance is a key pharmacokinetic parameter that quantifies the theoretical volume of body fluid from which a drug is completely removed within a specific time frame. Expressed as volume per unit time, it provides critical insights into drug dosing and helps anticipate potential side effects by revealing how efficiently the body eliminates a drug.

In the one-compartment open model for IV bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent volume of distribution to provide a quantitative measure of drug removal from the body.

Organ clearance is estimated by dividing an individual organ's elimination rate by the drug concentration presented to that organ, such as hepatic or renal clearance. Total body clearance represents the cumulative clearance by all eliminating organs combined, illustrating how the entire body processes the drug.

Hepatic clearance evaluates drug elimination specifically by the liver and is estimated by dividing the elimination rate by the drug concentration presented to the liver. It can be further categorized into hepatic blood flow rate-limited clearance and intrinsic capacity-limited clearance, reflecting different mechanisms of liver-mediated drug removal.

The method of residuals is a technique used to calculate clearance by separating multiexponential plasma concentration-time curves into their individual components. By analyzing these profiles and applying suitable equations, this method enables accurate estimation of clearance to understand drug elimination from the body.

The non-compartment method is used to estimate clearance for drugs with unknown or complex elimination rate processes. This model-independent approach provides an alternative to compartmental analysis when the specific elimination mechanisms cannot be clearly defined or characterized from available data.

Drug clearance in the kidneys and other organs is estimated similarly by dividing the elimination rate by the drug concentration presented to each organ. Total systemic clearance is the aggregate of all individual organ clearances, demonstrating how multiple organs collectively contribute to overall drug elimination from the body.